median followup was 24 months ( range 8 to 38 months ) in the 13 patients with seminoma and 28 months ( range 9 to 58 months ) in those with nonseminomatous tumors , and 13 ( 100 per cent ) and 12 ( 71 per cent ) , respectively , are alive without evidence of disease .
C0027651
tumors
C0012634
disease